BTN2A2, a new biomarker and therapeutic target for glioma

Heping Wang; Shanrui Pu; Haitao Xu; Lihong Yang; Lishi Shao; Xi Chen; Xiaobin Huang; Jun Pu

doi:doi:10.18632/aging.205039

← Back

Research Paper Volume 15, Issue 20 pp 10996—11011

BTN2A2, a new biomarker and therapeutic target for glioma

Figure 8. The correlation between BTN2A2 expression and immune checkpoint genes. (A, B) Correlation between BTN2A2 expression and immune checkpoint genes in patients with glioma using TCGA and TISIDB databases. (C, D) Analyzing the correlation between BTN2A2 expression and immune checkpoint genes in patients with glioma using Spearman^’s correlation.